Investors

|

Portal
Order
Home / Research / Publications / Multiomic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes

Innovation

Publications

Back

Multiomic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes

– Caris Life Sciences

Poster

Conclusions

  • RCC1 expression is a negative prognostic marker in NSCLC, PC, and CRC
  • Further studies to investigate this at the molecular level may be a potential opportunity for novel targeted drug development
Download Publication

Discover
More

  • An Artificial Intelligence (AI) model integrating multiscale foundation model histopathology representations with molecular and clinical features predicts early and late distant recurrence in TAILORx

    – Caris Life Sciences

    Manuscript

    Abstract We developed and validated IICM+, a multimodal model integrating clinicopathologic variables, transcriptomic features, and multiscale histopathology-derived image representations to predict distant recurrence in hormone… […]

  • Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence

    – Caris Life Sciences

    Manuscript

    Abstract Improved clinical outcomes are reported for patients with advanced pancreatic adenocarcinoma (PDAC) treated with first-line FOLFIRINOX/NALIRIFOX, but elderly patients with comorbidities are more often… […]
Learn More

Ready to Get Started on the Journey?